Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details


Treg Directed Therapy for Autoimmune Disorders Summit 2018

The pioneering Treg Directed Therapy for Autoimmune Disorders Summit is bringing together the expert Autoimmune Community. Learn And discover new approaches to improve the functionality of Treg cells.

Add this event to your calendar: iCal   Google Calendar

Who should attend?

Open to all


This is your first and only opportunity to listen to the most advanced clinical case studies from Nektar Therapeutics and Amgen which explore the use of IL-2 to enhance the expansion and activation of the Treg cells. Delve deeper with expert insights from Roche and ILTOO Pharma to understand how IL-2 at low doses could selectively stimulate Treg cells.

Identify yourself as a leader in this community and join the discussion exploring the challenges in translating a proof of concept in autoimmune therapies from animal models to clinic. This meeting will provide the platform for conversations to be had to accelerate the clinical translation of Treg directed therapies.


Conference Only (Earlybird ends Feb 23): USD 1999 Conference Only (Earlybird ends Mar 23): USD 2199 Conference Only (Earlybird ends Apr 20): USD 2399 Conference Only: USD 2799 Conference Academic Only (Earlybird ends Feb 23): USD 1399 Conference Academic Only (Earlybird ends Mar 23): USD 1599 Conference Academic Only (Earlybird ends Apr 20): USD 1799 Conference Academic Only: USD 1999 Workshop Only: USD 499


Georgina FitzGerald

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.